AC Immune S.A.

NASDAQ: ACIU · Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Aug 15, 2025, 3:59 PM
2.12
-1.17%
After-hours: Aug 15, 2025, 04:45 PM EDT

AC Immune S.A. Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
36.27M 78.49M 31.59M 82.22M
Short-Term Investments
129.21M 24.55M 91M 116M
Long-Term Investments
415K 361K 361K 363K
Other Long-Term Assets
n/a n/a 361K 363K
Receivables
2.2M 15.05M 800K 975K
Inventory
n/a n/a n/a -1.4M
Other Current Assets
n/a 622K n/a n/a
Total Current Assets
171.99M 125.15M 128.09M 202.63M
Property-Plant & Equipment
8.09M 6.88M 7.07M 8.03M
Goodwill & Intangibles
50.42M 50.42M 50.42M 50.42M
Total Long-Term Assets
58.92M 57.66M 57.84M 58.81M
Total Assets
230.91M 182.81M 185.94M 261.44M
Account Payables
2.66M 1.68M 929K 2M
Deferred Revenue
85.06M 138K 587K 717K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
100.84M 13.58M 11.48M 20.03M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
8.84M 5.77M 3.21M 7.1M
Total Long-Term Liabilities
17.8M 8.6M 5.47M 9.44M
Total Liabilities
118.64M 22.17M 16.95M 29.46M
Total Debt
5.43M 3.5M 2.8M 2.91M
Common Stock
2.23M 2.09M 1.8M 1.79M
Retained Earnings
-368.24M -316.2M -264.01M -200.94M
Comprehensive Income
-5K -51K 10K 0.00
Shareholders Equity
112.27M 160.64M 168.99M 231.98M
Total Investments
129.63M 24.91M 91.36M 116.36M